Gary Siegel

Gary is responsible for the preparation of the Company’s financial reporting, including reports filed with the Securities and Exchange Commission, or SEC. Gary has many years of experience working for public companies. Prior to joining Actinium, he was Controller at Bellerophon Therapeutics, Inc., a public medical device company, and prior to that, he was Vice President of Finance of Cogentix Medical, Inc., a public medical device company. From 2003 to 2013, Gary was with Genta Incorporated, a public biopharmaceutical company, where he progressed to be Vice President-Finance and Principal Financial Officer. Earlier in his career, Gary had a number of positions at Pfizer Inc. Gary have an MBA from Carnegie-Mellon University.